Systematic Reviews of Treatments for Chronic Obstructive Pulmonary Disease (COPD)

Follow the links below to find systematic reviews of the evidence for the effectiveness of treatments for COPD.

 

Created May 2008

Printer friendly page

40 Resources Found
Results 1 to 20 displayed.
1    2   
Title:   Nutritional supplementation for stable chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Low body weight is common in people with chronic obstructive pulmonary disease (COPD). It can impair their heart and lung function and reduce their ability to exercise and recover. Some degree of malnutrition is common in people with COPD but it is uncl...
Date:   Feb 2005
Title:   Short-acting beta2-agonists for stable chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review has shown that regular use for at least seven days of inhaled beta-2 medicines that relieve airways obstruction and can also improve the symptoms associated with chronic obstructive pulmonary disease (COPD) in most patients but not all. Pati...
Date:   May 2002
Title:   Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review looks at studies that compare the regular use for at least four weeks of different types of inhaled short-acting bronchodilator medication in people with chronic obstructive pulmonary disease (COPD, or emphysema/chronic bronchitis). There we...
Date:   Feb 2006
Title:   Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Shortness of breath is the main complaint of persons with chronic obstructive pulmonary disease (COPD). This symptom worsens during an exacerbation or 'flare' of COPD. Trials comparing ipratropium bromide versus beta-agonists showed no significant diffe...
Date:   Aug 2002
Title:   Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   There is strong evidence that vaccines can protect healthy persons against infection by the pneumococcus bacteria, but little is known about the effectiveness of the vaccine in persons with chronic obstructive pulmonary disease (COPD). The results from ...
Date:   Jul 2006
Title:   Oral theophylline for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Theophylline treatment is commonly used in people with chronic obstructive pulmonary disease (COPD). This systematic review shows that orally administered theophylline improves lung function and levels of oxygen and carbon dioxide in the blood. However,...
Date:   Apr 2002
Title:   Self-management education for patients with chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Chronic obstructive pulmonary disease (COPD) is characterised by frequent day by day fluctuations and repeated severe exacerbations are common. The idea of self-management is to teach patients the skills needed to carry out medical regimens specific to ...
Date:   Aug 2007
Title:   Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Mixtures of helium and oxygen (heliox) may make breathing easier, but there is not enough evidence from trials to show whether these mixtures can relieve attacks of COPD (chronic obstructive pulmonary disease)....
Date:   Nov 2000
Title:   Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review involved the assessment of different inhaler devices for delivery of inhaled bronchodilators in stable chronic obstructive pulmonary disease (COPD). Studies included in this review involved pressurised metered dose inhalers (pMDI) being comp...
Date:   Nov 2001
Title:   Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   In selected circumstances people with acute episodes of chronic obstructive pulmonary disease receiving 'hospital at home' services prefer it, and have similar outcomes to people who are hospitalised.
Date:   Aug 2003
Title:   Methylxanthines for exacerbations of chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Methylxanthine drugs such as aminophylline and theophylline are recommended for use in patients who have acute exacerbations (episodes) of chronic obstructive pulmonary disease, particularly for patients unresponsive to standard therapies. This review i...
Date:   Dec 2002
Title:   Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Steroid preventer medications given by inhaler ('inhaled steroids') help to reduce inflammation in the air passages of people with asthma. However it is uncertain whether these medications are beneficial in people with chronic obstructive pulmonary dise...
Date:   Jan 2007
Title:   Pulmonary rehabilitation for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   We report the second update of a meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. We wished to determine the impact of rehabilitation (defined as exercise training for at least four weeks with or without education an...
Date:   Jun 2006
Title:   Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   During an acute worsening of chronic obstructive pulmonary disease, there may be a worsening in airway function. Two different types of drugs may be given as inhaled therapy to improve this: anticholinergic drugs such as ipratropium and beta2-agonists. ...
Date:   Oct 2000
Title:   Short-term ambulatory oxygen for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Short-term studies indicate that people with chronic obstructive pulmonary disease respond to the administration of oxygen when they do exercise tests. Ambulatory oxygen is the use of supplemental oxygen during exercise and activities of daily living. O...
Date:   Jun 2005
Title:   Home care by outreach nursing for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Home visits for people with chronic lung disease (COPD - emphysema or chronic bronchitis) aim to help people maintain their health and need fewer hospital stays. The nurses aim to help people use their treatments well, provide education about coping str...
Date:   May 2001
Title:   Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Some people with advanced chronic lung disease (COPD - chronic bronchitis or emphysema) can experience breathing failure. This involves chemical changes which in turn can lower the drive to breathe. The drug acetazolamide is used for mountain sickness, ...
Date:   Sep 2000
Title:   Cardioselective beta-blockers for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Long term treatment with beta-blocker medication reduces the risk of death in patients with hypertension, heart failure and coronary artery disease, yet patients with COPD in addition to their cardiovascular disease seldom receive these medicines becaus...
Date:   Jul 2005
Title:   Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Combinations of two classes of medication in one inhaler have been developed to treat people with COPD. Two types of combined inhaler exist currently: budesonide/formoterol (BDF - 'Symbicort'), and fluticasone/salmeterol (FPS - 'Advair' or 'Seretide'). ...
Date:   Aug 2007
Title:   Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review evaluated the benefits of nocturnal NIPPV (non invasive positive pressure ventilation) in COPD patients on lung function, blood gases, six minute walking distance (6MWD), dyspnoea (during daily activities), health status (health-related qual...
Date:   Jan 2002
Results 1 to 20 displayed.
1    2